CONTROLLED RELEASE SALBUTAMOL TABLETS VERSUS SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN THE CONTROL OF REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE

被引：6

作者：

VYSE, T ^{[1
]}

COCHRANE, GM ^{[1
]}

机构：

[1] GUYS HOSP,DEPT THORAC MED,ST THOMAS ST,LONDON SE1 9RT,ENGLAND

来源：

关键词：

D O I：

10.1177/030006058901700114

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：93 / 98

页数：6

共 12 条

[1]

BARNES PJ, 1982, LANCET, V1, P299

[2]

DAHL R, 1988, EUR RESPIR J, V1, pS206

[3]

HERRMANN G, 1937, J LAB CLIN MED, V23, P135

[4] 2-PERIOD CROSSOVER CLINICAL-TRIAL [J].

HILLS, M ;

ARMITAGE, P .

[5]

HORN CR, 1984, LANCET, V1, P1143

[6]

JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349

MAESEN, FPV ;

SMEETS, JJ .

[8]

RALL TW, 1985, PHARMACOL BASIS THER, P589

[9]

SYKES RS, 1987, J ALLERGY CLIN IMMUN, V79, P152

[10]

VOZEH S, 1982, AM REV RESPIR DIS, V125, P181